Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL1190711 (BAY-613606) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
spleen associated tyrosine kinase/Tyrosine-protein kinase SYK in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2599] [GtoPdb: 2230] [UniProtKB: P43405] | ||||||||
ChEMBL | Inhibition of SYK | B | 8.12 | pKi | 7.5 | nM | Ki | J Med Chem (2012) 55: 3614-3643 [PMID:22257213] |
GtoPdb | - | - | 7.59 | pIC50 | 25.5 | nM | IC50 | PLoS ONE (2012) 7: e41343 [PMID:22815993] |
ChEMBL | Inhibition of SYK in human Ramos B cells assessed as reduction in Ca2+ release | B | 7.09 | pEC50 | 81 | nM | EC50 | J Med Chem (2012) 55: 3614-3643 [PMID:22257213] |
ChEMBL | Inhibition of SYK in human U937 cells assessed as reduction FcgammaR-mediated superoxide production | B | 7.28 | pEC50 | 52 | nM | EC50 | J Med Chem (2012) 55: 3614-3643 [PMID:22257213] |
ChEMBL | Inhibition of SYK in peripheral blood monocytes assessed as reduction FcgammaR-mediated superoxide production | B | 7.92 | pEC50 | 12 | nM | EC50 | J Med Chem (2012) 55: 3614-3643 [PMID:22257213] |
component of inhibitor of nuclear factor kappa B kinase complex in Human [GtoPdb: 1989] [UniProtKB: O15111] | ||||||||
GtoPdb | - | - | 7.35 | pKi | 45 | nM | Ki | PLoS ONE (2016) 11: e0150339 [PMID:26930276] |
mitogen-activated protein kinase kinase kinase kinase 2 in Human [GtoPdb: 2086] [UniProtKB: Q12851] | ||||||||
GtoPdb | - | - | 7.95 | pIC50 | 11.3 | nM | IC50 | PLoS ONE (2012) 7: e41343 [PMID:22815993] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]